Predictive Performance of Cell-Free Nucleic Acid-Based Multi-Cancer Early Detection Tests: A Systematic Review
Authors:
Open Access
- 4 October 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 70 (1) , 90-101
Abstract
Background: Cancer-screening tests that can detect multiple cancer types, or multi-cancer early detection (MCED) tests, have emerged recently as a potential new tool in decreasing cancer morbidity and mortality. Most MCED assays are based on detecting cell-free tumor DNA (CF-DNA) in the blood. MCEDs offer the potential for screening for cancer organ sites with high mortality, both with and without recommended screening. However, their clinical utility has not been established. Before clinical utility can be established, the clinical validity of MCEDs, i.e., their ability to predict cancer status, must be demonstrated. In this study we performed a systematic review of the predictive ability for cancer of cell-free-nucleic acid-based MCED tests. Content: We searched PubMed for relevant publications from January 2017 to February 2023, using MeSH terms related to multi-cancer detection, circulating DNA, and related concepts. Of 1811 publications assessed, 61 were reviewed in depth and 20 are included in this review. For almost all studies, the cancer cases were assessed at time of diagnosis. Most studies reported specificity (generally 95% or higher) and overall sensitivity (73% median). The median number of cancer types assessed per assay was 5. Many studies also reported sensitivity by stage and/or cancer type. Sensitivity generally increased with stage. Summary: To date, relatively few published studies have assessed the clinical validity of MCED tests. Most used cancer cases assessed at diagnosis, with generally high specificity and variable sensitivity depending on cancer type and stage. The next steps should be testing in the intended-use population, i.e., asymptomatic persons.Keywords
This publication has 38 references indexed in Scilit:
- Detection and localization of surgically resectable cancers with a multi-analyte blood testScience, 2018
- A better confidence interval for the sensitivity at a fixed level of specificity for diagnostic tests with continuous endpointsStatistical Methods in Medical Research, 2016
- Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force RecommendationAnnals of Internal Medicine, 2016
- Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided DetectionJAMA Internal Medicine, 2015
- ROC Curves for Low-Dose CT in the National Lung Screening TrialJournal of Medical Screening, 2013
- Regulatory Approval Pathways for Molecular Diagnostic Technology2011
- An empirical assessment of validation practices for molecular classifiersBriefings in Bioinformatics, 2011
- The psychological impact of mammographic screening. A systematic reviewPsycho-Oncology, 2005
- Phases of Biomarker Development for Early Detection of CancerJNCI: Journal of the National Cancer Institute, 2001
- Comparison of quantitative diagnostic tests: Type I error, power, and sample sizeStatistics in Medicine, 1987